KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.76 Cr | ₹0.76 Cr | ₹0.76 Cr | ₹0.76 Cr | ₹0.76 Cr |
What is the latest Contingent Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.76 Cr |
| Mar2024 | ₹0.76 Cr |
| Mar2023 | ₹0.76 Cr |
| Mar2022 | ₹0.76 Cr |
| Mar2021 | ₹0.76 Cr |
How is Contingent Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.76 Cr | 0.00 | |
| Mar2024 | ₹0.76 Cr | 0.00 | |
| Mar2023 | ₹0.76 Cr | 0.00 | |
| Mar2022 | ₹0.76 Cr | 0.00 | |
| Mar2021 | ₹0.76 Cr | - | |
Compare Contingent Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹549.5 Cr | -1% | -8.5% | -2.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -1% |
-8.5% |
-2.4% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses